This inventor holds 2 USPTO granted patents. Top assignee: Elekta Ab (Publ). Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: Shakil Ahmed Awan: Innovator in Radiotherapeutic Technology
Introduction
Shakil Ahmed Awan is a notable inventor based in Crawley, GB. He has made significant contributions to the field of radiotherapy through his innovative patents. With a total of 2 patents, Awan's work focuses on enhancing the capabilities of radiotherapeutic apparatuses.
Latest Patents
One of his latest patents involves a machine vision system that utilizes fluorescing markers. These markers are designed to mark elements such as leaves of a multi-leaf collimator and reference points within the field of view. The markers are illuminated with light that causes them to fluoresce at a different wavelength than the illuminating light. This fluorescence is detected by a camera, allowing for images to be captured with increased contrast. The invention provides a multi-leaf collimator for a radiotherapeutic apparatus, which includes at least one leaf featuring a fluorescent marker. The markers typically emit light at a longer wavelength than the incident light, enabling the use of filters to distinguish the emitted light. Ruby is identified as a suitable material for these fluorescent markers. The radiotherapeutic apparatus also comprises a camera arranged to view the fluorescent markers, enhancing the overall imaging process.
Career Highlights
Shakil Ahmed Awan is currently associated with Elekta AB (Publ), a company known for its advancements in medical technology. His work at Elekta has allowed him to focus on developing innovative solutions that improve patient outcomes in radiotherapy.
Collaborations
Awan collaborates with Adrian Maxwell Smith, contributing to the development of cutting-edge technologies in the field.
Conclusion
Shakil Ahmed Awan's contributions to radiotherapeutic technology through his patents demonstrate his commitment to innovation and improving medical practices. His work continues to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
